Lexaria Bioscience (LEXX) Liabilities and Shareholders Equity (2011 - 2026)
Lexaria Bioscience (LEXX) recorded Liabilities and Shareholders Equity of $4.78 million in fiscal Q3 2026 (quarter ended May 31, 2026), down 29.1% from $6.74 million a year earlier and down 26.3% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
At the end of FY2025 (ended Aug 31, 2025), Lexaria Bioscience reported Liabilities and Shareholders Equity of $4.18 million, down 52.9% from FY2024.
- Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 8.1% (FY2020 to FY2025).
- Across earlier fiscal years, Liabilities and Shareholders Equity came in at $8.87 million in FY2024 (+187.5%), $3.08 million in FY2023 (-60.6%), $7.83 million in FY2022 (-41.0%) and $13.27 million in FY2021 (+369.1%).
- Quarterly Liabilities and Shareholders Equity has ranged from $3.08 million in fiscal Q4 2023 to $13.27 million in fiscal Q4 2021 over the past five years.
- On a year-over-year basis, Liabilities and Shareholders Equity has declined for five consecutive quarters, with growth averaging 27.0% over the last eight quarters.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 440.2% in fiscal Q1 2022, against a decline of 60.6% in fiscal Q4 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $6.49 million (Q2 2026), $6.05 million (Q1 2026) and $4.18 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Lexaria Bioscience | 3.26 Mn | -12.39 Mn | - | 4.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 4.78 Mn |
| Feb 28, 2026 | 6.49 Mn |
| Nov 30, 2025 | 6.05 Mn |
| Aug 31, 2025 | 4.18 Mn |
| May 31, 2025 | 6.74 Mn |
| Feb 28, 2025 | 8.68 Mn |
| Nov 30, 2024 | 9.79 Mn |
| Aug 31, 2024 | 8.87 Mn |
| May 31, 2024 | 10.02 Mn |
| Feb 29, 2024 | 6.35 Mn |
| Nov 30, 2023 | 3.63 Mn |
| Aug 31, 2023 | 3.08 Mn |
| May 31, 2023 | 5.24 Mn |
| Feb 28, 2023 | 4.85 Mn |
| Nov 30, 2022 | 6.21 Mn |
| Aug 31, 2022 | 7.83 Mn |
| May 31, 2022 | 9.14 Mn |
| Feb 28, 2022 | 11.41 Mn |
| Nov 30, 2021 | 11.75 Mn |
| Aug 31, 2021 | 13.27 Mn |
API Access
Lexaria Bioscience Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();